All stock reports

CONCORDBIO evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-04T23:40:35.930547+00:00

Metrics

latest_annual_period
2026-03-31
revenue
10548907000.0
net_income
2609059000.0
operating_cash_flow
2692778000.0
free_cash_flow
1741267000.0
total_assets
22347271000.0
total_liabilities
2195891000.0
total_equity
20170613000.0
cash
4156426999.0
total_debt
23156000.0
revenue_growth
-0.12098807178046855
earnings_growth
-0.2979650055981249
net_margin
0.2473297944516906
roe
0.12934951456358812
debt_to_equity
0.0011480067561655167
cash_conversion
1.032087814035635
free_cash_flow_margin
0.16506610590082935
trailing_pe
49.7214
forward_pe
0.0
peg_ratio
Not supplied
price_to_book
7.0797
dividend_yield
0.0

Other positional research

No qualifying opportunity

No candidate at another positional horizon in the coherent source run.

  • No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
Decision ID
decision-edbd6504a0c2b6001604eac2c94e63857d6c7e1e1742329df73c75a9f41bf0e9
Policy
stock-decisions-v1
Evidence bundle hash
ab7898973a9032b9fed25f3fb8c57bc6aab661d161224fbaca8995d6caf392a3
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 09b28fba89680ea84a26b4237fbf2e5c666a9f60730b75c97312bbb291343ac5
  • daily-price: a7da7741f7be7a3cfc09abdcdad8e8474e523c406417ec9de25d08c3a3c170e0
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: VERIFIED. The cached closing price on 2026-10-01 was INR 1374.10. The trailing 5-session price return was -7.08%. The trailing 20-session price return was -4.89%. The trailing 60-session price return was 9.73%. The trailing 250-session price return was -11.69%.

Risks

Average cached traded value over twenty sessions was INR 245,432,316. The closing price was -16.11% below its highest close in the available trailing year. The cached financial metric revenue growth is -0.12098807178046855. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

The cached financial metric latest annual period is 2026-03-31. The cached financial metric net margin is 0.2473297944516906. The cached financial metric roe is 0.12934951456358812. The cached financial metric debt to equity is 0.0011480067561655167. The cached financial metric cash conversion is 1.032087814035635. The cached financial metric free cash flow margin is 0.16506610590082935.

Cached observations and evidence limits